Prosight Management, LP Care Dx, Inc. Transaction History
Prosight Management, LP
- $369 Million
- Q2 2025
A detailed history of Prosight Management, LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 302,808 shares of CDNA stock, worth $4.61 Million. This represents 1.6% of its overall portfolio holdings.
Number of Shares
302,808
Previous 136,593
121.69%
Holding current value
$4.61 Million
Previous $2.42 Million
144.06%
% of portfolio
1.6%
Previous 0.86%
Shares
3 transactions
Others Institutions Holding CDNA
# of Institutions
213Shares Held
55.5MCall Options Held
85KPut Options Held
33.1K-
Black Rock Inc. New York, NY5.29MShares$80.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$74.7 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.54MShares$38.7 Million0.01% of portfolio
-
Bamco Inc New York, NY2.44MShares$37.1 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$33.2 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $814M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...